Your email has been successfully added to our mailing list.

×
0.0572289156626507 0.0572289156626507 0.114457831325301 0.114457831325301 0.0843373493975904 0.0843373493975904 0.0903915662650604 0.0993975903614459
Stock impact report

BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS [Reuters]

FLEX PHARMA (FLKS) 
Last flex pharma earnings: 8/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.flex-pharma.com/investor-overview
Company Research Source: Reuters
BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS | Reuters Reuters Staff 1 Min Read Nov 6 (Reuters) - Flex Pharma Inc * Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS * Flex Pharma - ?data from exploratory phase 2 trial of FLX-787 showed statistically significant reduction in cramp-associated pain intensity & stiffness * Flex Pharma Inc - ?FLX-787 was generally well tolerated? Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com) All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS Nov 6 (Reuters) - Flex Pharma Inc * Flex Pharma reports positive topline data from exploratory phase 2 trial of FLX-787 in ALS * Flex Pharma - ?data from exploratory phase 2 trial of FLX-787 showed Show less Read more
Impact Snapshot
Event Time:
FLKS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for FLKS alerts
Opt-in for
FLKS alerts

from News Quantified
Opt-in for
FLKS alerts

from News Quantified